Provided by Tiger Trade Technology Pte. Ltd.

Unicycive Therapeutics, Inc.

5.63
+0.18003.30%
Post-market: 5.61-0.0200-0.36%19:30 EDT
Volume:1.01M
Turnover:5.69M
Market Cap:156.83M
PE:-3.61
High:5.77
Open:5.51
Low:5.50
Close:5.45
52wk High:8.74
52wk Low:3.71
Shares:27.86M
Float Shares:25.82M
Volume Ratio:1.42
T/O Rate:3.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5585
EPS(LYR):-1.6715
ROE:-101.07%
ROA:-40.59%
PB:2.94
PE(LYR):-3.37

Loading ...

Unicycive Therapeutics price target raised to $15 from $13 at Benchmark

TIPRANKS
·
Aug 20

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Reuters
·
Aug 20

Unicycive Therapeutics price target lowered to $20 from $22 at B. Riley

TIPRANKS
·
Aug 17

Unicycive Therapeutics Posts Corporate Presentation on Kidney Disease Drug Pipeline, Led by OLC for Dialysis Hyperphosphatemia

Reuters
·
Aug 17

Clene Q2 Net Loss Widens on Higher Other Expenses

Reuters
·
Aug 14

Eledon Pharmaceuticals Q2 Net Loss Widens on Warrant Liability Changes

Reuters
·
Aug 14

Unicycive Therapeutics Price Target Cut to $20.00/Share from $22.00 by B. Riley Securities

Dow Jones
·
Aug 13

B. Riley Securities Reaffirms Their Buy Rating on Unicycive Therapeutics (UNCY)

TIPRANKS
·
Aug 13

B. Riley Adjusts Price Target on Unicycive Therapeutics to $20 From $22, Maintains Buy Rating

MT Newswires Live
·
Aug 13

Unicycive Therapeutics Inc : Guggenheim Cuts Target Price to $25 from $37

THOMSON REUTERS
·
Aug 13

Inovio Q2 Net Loss Narrows on Warrant Gain, Lower Costs

Reuters
·
Aug 13

Unicycive Rises on Narrower Quarterly Loss

Reuters
·
Aug 13

Unicycive Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Unicycive Therapeutics Q2 Net Loss Narrows on Warrant Liability Change

Reuters
·
Aug 12

Unicycive Therapeutics Q2 EPS USD -0.06

THOMSON REUTERS
·
Aug 12

Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 12

Unicycive Therapeutics - Q2 Net Loss was $1.70 Mln or $0.06 Per Share

THOMSON REUTERS
·
Aug 12

Unicycive Therapeutics Q2 EPS $(0.06) Beats $(0.34) Estimate

Benzinga Earnings
·
Aug 12

Unicycive Net Loss Widens 147% to USD 14.55 Million in FY26 First Half

Reuters
·
Aug 12

Unicycive Therapeutics Inc Expected to Post a Loss of 34 Cents a Share - Earnings Preview

Reuters
·
Aug 10